Louis Moore Bacon's CRL Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 0 shares of Charles River Laboratories International, Inc. (CRL) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, Louis Moore Bacon has initiated a new position in CRL, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2025, adding 27,438 shares. Largest reduction occurred in Q3 2015, reducing 65,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
Louis Moore Bacon's Charles River Laboratories International Investment FAQs
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 48,925 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $7.65 M.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.11% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Charles River Laboratories International, Inc. (CRL) was 65,000 shares, as reported at the end of Q2 2015.